These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9761423)
1. In vitro comparison of two NONOates (novel nitric oxide donors) on rat pulmonary arteries. Homer K; Wanstall J Eur J Pharmacol; 1998 Aug; 356(1):49-57. PubMed ID: 9761423 [TBL] [Abstract][Full Text] [Related]
2. Inhibition by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) of responses to nitric oxide-donors in rat pulmonary artery: influence of the mechanism of nitric oxide generation. Homer KL; Fiore SA; Wanstall JC J Pharm Pharmacol; 1999 Feb; 51(2):135-9. PubMed ID: 10217311 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate. Homer KL; Wanstall JC Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580 [TBL] [Abstract][Full Text] [Related]
4. Cyclic GMP-independent relaxation of rat pulmonary artery by spermine NONOate, a diazeniumdiolate nitric oxide donor. Homer KL; Wanstall JC Br J Pharmacol; 2000 Oct; 131(4):673-82. PubMed ID: 11030715 [TBL] [Abstract][Full Text] [Related]
5. Extracellular nitric oxide release mediates soluble guanylate cyclase-independent vasodilator action of spermine NONOate: comparison with other nitric oxide donors in isolated rat femoral arteries. Miller MR; Okubo K; Roseberry MJ; Webb DJ; Megson IL J Cardiovasc Pharmacol; 2004 Mar; 43(3):440-51. PubMed ID: 15076229 [TBL] [Abstract][Full Text] [Related]
6. The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide. Onoue H; Katusic ZS Brain Res; 1998 Feb; 785(1):107-13. PubMed ID: 9526059 [TBL] [Abstract][Full Text] [Related]
7. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation. Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542 [TBL] [Abstract][Full Text] [Related]
8. Contribution of 20-HETE to vasodilator actions of nitric oxide in the cerebral microcirculation. Alonso-Galicia M; Hudetz AG; Shen H; Harder DR; Roman RJ Stroke; 1999 Dec; 30(12):2727-34; discussion 2734. PubMed ID: 10583004 [TBL] [Abstract][Full Text] [Related]
9. Platelet inhibitory effects of the nitric oxide donor drug MAHMA NONOate in vivo in rats. Homer KL; Wanstall JC Eur J Pharmacol; 2003 Dec; 482(1-3):265-70. PubMed ID: 14660031 [TBL] [Abstract][Full Text] [Related]
10. Effects of nitric oxide on P2Y receptor resensitization in spontaneously hypertensive rat mesangial cells. Liu R; Persson AE J Hypertens; 2002 Sep; 20(9):1835-42. PubMed ID: 12195127 [TBL] [Abstract][Full Text] [Related]
11. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708 [TBL] [Abstract][Full Text] [Related]